Sodium intake, ACE inhibition, and progression to ESRD

Journal of the American Society of Nephrology

Volumn 23, Issue 1, 2012, Pages 10-12

  Luther, James M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; RAMIPRIL;

DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; ENZYME INHIBITION; HEART FAILURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL;

EID: 84855614151     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011111107     Document Type: Editorial

References (11)

1. Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group: Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med 168: 832-839, 2008 (Pubitemid 351620085)
2. Titze J, Ritz E: Salt and its effect on blood pressure and target organ damage: New pieces in an old puzzle. J Nephrol 22: 177-189, 2009
3. Bakris GL, Smith A: Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann Intern Med 125: 201-204, 1996 (Pubitemid 126449263)
4. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 23: 165-173, 2012
5. Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6: 640-647, 2011
6. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; Finn Diane Study Group: The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34: 861-866, 2011
7. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovský J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA; European Project on Genes in Hypertension (EPOGH) Investigators: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305: 1777-1785, 2011
8. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334: 885-888, 2007 (Pubitemid 46724330)
9. Centers for Disease Control and Prevention (CDC): Usual sodium intakes compared with current dietary guidelines: United States, 2005-2008. MMWR Morb Mortal Wkly Rep 60: 1413-1417, 2011
10. Jalal DI, Smits G, Johnson RJ, Chonchol M: Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21: 1543-1549, 2010
11. Wright JA, Cavanaugh KL: Dietary sodium in chronic kidney disease: A comprehensive approach. Semin Dial 23: 415-421, 2010